Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapy.

Details

Language :

English

ISSN :

15384047

Volume :

15

Issue :

3

Database :

Academic Search Index

Journal :

Cancer Biology & Therapy

Publication Type :

Academic Journal

Accession number :

94827886

Full Text :

https://doi.org/10.4161/cbt.27327